These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 34856338)
21. Long-term effects of beta-blocker use on lung function in Japanese patients with chronic obstructive pulmonary disease. Oda N; Miyahara N; Ichikawa H; Tanimoto Y; Kajimoto K; Sakugawa M; Kawai H; Taniguchi A; Morichika D; Tanimoto M; Kanehiro A; Kiura K Int J Chron Obstruct Pulmon Dis; 2017; 12():1119-1124. PubMed ID: 28435245 [TBL] [Abstract][Full Text] [Related]
22. β-Blockers for the prevention of acute exacerbations of chronic obstructive pulmonary disease (βLOCK COPD): a randomised controlled study protocol. Bhatt SP; Connett JE; Voelker H; Lindberg SM; Westfall E; Wells JM; Lazarus SC; Criner GJ; Dransfield MT BMJ Open; 2016 Jun; 6(6):e012292. PubMed ID: 27267111 [TBL] [Abstract][Full Text] [Related]
23. Rates of hospitalizations and emergency department visits in patients with asthma and chronic obstructive pulmonary disease taking beta-blockers. Brooks TW; Creekmore FM; Young DC; Asche CV; Oberg B; Samuelson WM Pharmacotherapy; 2007 May; 27(5):684-90. PubMed ID: 17461703 [TBL] [Abstract][Full Text] [Related]
24. Prophylactic antibiotics for adults with chronic obstructive pulmonary disease: a network meta-analysis. Janjua S; Mathioudakis AG; Fortescue R; Walker RA; Sharif S; Threapleton CJ; Dias S Cochrane Database Syst Rev; 2021 Jan; 1(1):CD013198. PubMed ID: 33448349 [TBL] [Abstract][Full Text] [Related]
25. Use of the oral beta blocker bisoprolol to reduce the rate of exacerbation in people with chronic obstructive pulmonary disease (COPD): a randomised controlled trial (BICS). Cotton S; Devereux G; Abbas H; Briggs A; Campbell K; Chaudhuri R; Choudhury G; Dawson D; De Soyza A; Fielding S; Gompertz S; Haughney J; Lang CC; Lee AJ; MacLennan G; MacNee W; McCormack K; McMeekin N; Mills NL; Morice A; Norrie J; Petrie MC; Price D; Short P; Vestbo J; Walker P; Wedzicha J; Wilson A; Lipworth BJ Trials; 2022 Apr; 23(1):307. PubMed ID: 35422024 [TBL] [Abstract][Full Text] [Related]
26. Tailored or adapted interventions for adults with chronic obstructive pulmonary disease and at least one other long-term condition: a mixed methods review. Dennett EJ; Janjua S; Stovold E; Harrison SL; McDonnell MJ; Holland AE Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013384. PubMed ID: 34309831 [TBL] [Abstract][Full Text] [Related]
27. Use of beta-blockers in patients with COPD. Andrus MR; Holloway KP; Clark DB Ann Pharmacother; 2004 Jan; 38(1):142-5. PubMed ID: 14742808 [TBL] [Abstract][Full Text] [Related]
28. Use of beta blockers and the risk of death in hospitalised patients with acute exacerbations of COPD. Dransfield MT; Rowe SM; Johnson JE; Bailey WC; Gerald LB Thorax; 2008 Apr; 63(4):301-5. PubMed ID: 17951276 [TBL] [Abstract][Full Text] [Related]
29. [Use of beta blockers in cardiovascular diseases and bronchial asthma/COPD]. Glaab T; Weiss T Internist (Berl); 2004 Feb; 45(2):221-7. PubMed ID: 14991165 [TBL] [Abstract][Full Text] [Related]
30. Combined aclidinium bromide and long-acting beta2-agonist for chronic obstructive pulmonary disease (COPD). Ni H; Moe S; Soe Z; Myint KT; Viswanathan KN Cochrane Database Syst Rev; 2018 Dec; 12(12):CD011594. PubMed ID: 30536566 [TBL] [Abstract][Full Text] [Related]
31. Beta-blocker use and COPD mortality: a systematic review and meta-analysis. Etminan M; Jafari S; Carleton B; FitzGerald JM BMC Pulm Med; 2012 Sep; 12():48. PubMed ID: 22947076 [TBL] [Abstract][Full Text] [Related]
32. Clinical inquiries. Do beta-blockers worsen respiratory status for patients with COPD? Baselli LM; Oswald MA; Nashelsky JM J Fam Pract; 2005 May; 54(5):472-3. PubMed ID: 15865911 [No Abstract] [Full Text] [Related]
33. Effect of beta-blockers on exacerbation rate and lung function in chronic obstructive pulmonary disease (COPD). Duffy S; Marron R; Voelker H; Albert R; Connett J; Bailey W; Casaburi R; Cooper JA; Curtis JL; Dransfield M; Han MK; Make B; Marchetti N; Martinez F; Lazarus S; Niewoehner D; Scanlon PD; Sciurba F; Scharf S; Reed RM; Washko G; Woodruff P; McEvoy C; Aaron S; Sin D; Criner GJ; Respir Res; 2017 Jun; 18(1):124. PubMed ID: 28629419 [TBL] [Abstract][Full Text] [Related]
36. Effectiveness and safety of concurrent beta-blockers and inhaled bronchodilators in COPD with cardiovascular comorbidities. Corrao S; Brunori G; Lupo U; Perticone F Eur Respir Rev; 2017 Sep; 26(145):. PubMed ID: 28794142 [TBL] [Abstract][Full Text] [Related]
37. Beta-blocker Use in Moderate and Severe Chronic Obstructive Pulmonary Disease. Zvizdic F; Begic E; Mujakovic A; Hodzic E; Prnjavorac B; Bedak O; Custovic F; Bradaric H; Durak-Nalbantic A Med Arch; 2019 Apr; 73(2):72-75. PubMed ID: 31391690 [TBL] [Abstract][Full Text] [Related]
38. Self-management interventions including action plans for exacerbations versus usual care in patients with chronic obstructive pulmonary disease. Lenferink A; Brusse-Keizer M; van der Valk PD; Frith PA; Zwerink M; Monninkhof EM; van der Palen J; Effing TW Cochrane Database Syst Rev; 2017 Aug; 8(8):CD011682. PubMed ID: 28777450 [TBL] [Abstract][Full Text] [Related]
39. Aclidinium bromide for stable chronic obstructive pulmonary disease. Ni H; Soe Z; Moe S Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD010509. PubMed ID: 25234126 [TBL] [Abstract][Full Text] [Related]
40. The role of beta-blockers in the management of chronic obstructive pulmonary disease. Leitao Filho FS; Alotaibi NM; Yamasaki K; Ngan DA; Sin DD Expert Rev Respir Med; 2018 Feb; 12(2):125-135. PubMed ID: 29258360 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]